Purchase Order 75N95021P00006

Award Date 11/1/20
Potential Completion Date 10/31/23
Potential Value $1.6M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Birmingham, AL 35242, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
6
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $150,000.00 firm fixed-price purchase order to Antelope Flats, LLC, a small business subchapter S corporation, for new media advertising platform services. The contract has a period of performance from September 4, 2018 to September 3, 2019. The purpose is to design and implement recruitment strategies to identify and attract eligible volunteer participants for the National...
The National Institutes of Health National Institute on Drug Abuse awarded a $977,581 time and materials purchase order to Capital Consulting Corporation to provide remuneration, travel, and subsistence support services for research participants in clinical studies under the Institute's Intramural Research Program. The solicitation sought proposals to disburse participant payments, arrange transportation and meals, purchase supplies, and perform administrative tasks like reporting in...
This $150,000 purchase order contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Hope Health Systems, Inc., a minority-owned for-profit organization, to provide grassroots outreach and community partnership services to support the recruitment of research participants for the NIDA Intramural Research Program (NIDA IRP) clinical studies. The contract covers services such as establishing community partnerships, conducting targeted outreach...
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $206,910.64 firm fixed price delivery order to Medical Science & Computing, LLC. This order was issued against the Scientific, Operations, and Administrative Resources to the National Institutes of Health indefinite-delivery/indefinite-quantity multiple award contract vehicle to provide research support services to the Bethesda, Maryland facility. No subcontractors or set...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $10,465 firm fixed price purchase order to Cambrex High Point, Inc. to support retesting of the GLWL-01 reference standard and project specific funding. Cambrex will perform the work in Baltimore, Maryland over a one year period from July 2023 through July 2024. The National Institute on Drug Abuse conducts important biomedical research on drug abuse and addiction to improve...
The U.S. National Institute on Drug Abuse (NIDA) awarded a $1,460,000.00 delivery order contract to IQ Solutions, Inc., a minority-owned, woman-owned small business, to provide research support services for the ABCD Study and HBCD Study. This contract is part of the Public Information and Communications Services II (PICS II) indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract period of performance is from September 27, 2021 to September 26, 2022, with a total period...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $43,061.60 firm fixed price purchase order to Med Associates, Inc. for self-administration chambers to support research into brain mechanisms of compulsive drug use. Per the original solicitation, the Neuroimaging Research Branch requires additional self-administration training apparatuses for laboratory rats to self-administer compounds like methamphetamine while applying...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $123,764.67 firm fixed price delivery order against the Scientific, Operations, and Administrative Resources to the National Institutes of Health indefinite-delivery/indefinite-quantity multiple award contract vehicle. Medical Science & Computing, LLC will serve as the prime contractor providing research support and administrative services to NIH NIDA under the terms of...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to Altasciences Clinical Kansas Inc., a for-profit contract research organization (CRO). The $1,340,461.88 firm fixed-price delivery order is for a clinical trial to assess the safety, tolerability, and pharmacokinetics of an investigational agent for substance use disorder (SUD) treatment. The contract is part of NIDA's $21 million indefinite delivery contract N01DA-23-8935, which supports...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $74,550.00 firm fixed price delivery order to 22nd Century Technologies, Inc., a minority-owned small business. This task order is part of the larger Scientific, Operations, and Administrative Resources (SOAR) to the National Institutes of Health (NIH) indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. The order requires 22nd Century Technologies to provide...

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1,570,341 purchase order to Antelope Flats, LLC to provide targeted participant marketing and advertising services in support of clinical research studies conducted by NIDA's Intramural Research Program. The solicitation sought proposals to develop customized recruitment strategies and campaigns for each protocol to enroll eligible research participants, including those with substance use disorders and healthy controls, in human studies involving substances such as nicotine, alcohol, cocaine, marijuana and opioids. The period of performance is one base year from November 1, 2020 to October 31, 2021 with two one-year option periods. This total small business set-aside requirement is to recruit participants primarily in the Greater Baltimore and Washington D.C. areas to obtain targeted enrollment numbers within study timelines.

Generated 12/29/23, 3:19 PM